HeraMED Ltd (HMD)

Sydney
Currency in AUD
0.016
0.000(0.00%)
Closed·
HMD Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
0.0160.017
52 wk Range
0.0130.031
Key Statistics
Edit
Bid/Ask
0.017 / 0.016
Prev. Close
0.016
Open
0.016
Day's Range
0.016-0.017
52 wk Range
0.013-0.031
Volume
1.31M
Average Volume (3m)
1.66M
1-Year Change
-8.57%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

HeraMED Ltd Company Profile

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform; and Broward Health for deployment of its HeraCARE to deliver care outcomes for pregnant mothers. HeraMED Limited was founded in 2011 and is based in Camberwell, Australia.

Compare HMD to Peers and Sector

Metrics to compare
HMD
Peers
Sector
Relationship
P/E Ratio
−2.6x−3.0x−0.5x
PEG Ratio
−0.04−0.030.00
Price/Book
5.1x3.0x2.6x
Price / LTM Sales
38.5x2.4x2.9x
Upside (Analyst Target)
-113.3%57.1%
Fair Value Upside
Unlock15.2%9.0%Unlock

Earnings

Latest Release
Feb 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
183.44K / --
EPS Revisions
Last 90 days

FAQ

What Is the HeraMED (HMD) Stock Price Today?

The HeraMED stock price today is 0.02

What Stock Exchange Does HeraMED Trade On?

HeraMED is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for HeraMED?

The stock symbol for HeraMED is "HMD."

What Is the HeraMED Market Cap?

As of today, HeraMED market cap is 14.01M.

What is HeraMED Earnings Per Share?

The HeraMED EPS is -0.01.

From a Technical Analysis Perspective, Is HMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.